Best Price* ₹ 138.58 MRP ₹ 169.00
(Inclusive of all taxes) *10 Tablet(s) in a Strip * Mkt: Glenmark Pharmaceuticals Ltd * Country of Origin: India * Delivery charges if applicable will be applied at checkout

Availability & Expiry

Delivering To

INTRODUCTION

SITAZIT D 10/50 TABLET is a combination of Dapagliflozin and Sitagliptin which belongs to the group of medicines called Antidiabetic agents. It is used in adults to treat type II diabetes mellitus which is inadequately controlled on metformin monotherapy.

Type 2 diabetes is a condition in which your body does not make enough insulin and the insulin that is produced does not work as well as it should. This results in sugar (glucose) build-up in the blood and thus high blood sugar levels.

SITAZIT D 10/50 TABLET is not recommended for use in patients having severe kidney problems or those on dialysis. Before taking SITAZIT D 10/50 TABLET, inform your doctor if you have inflammation of the pancreas, gallstones, alcohol dependence, or very high levels of triglycerides (a form of fat) in the blood or any heart, kidney or liver problems.

SITAZIT D 10/50 TABLET should be used in pregnant women only if considered clearly necessary. SITAZIT D 10/50 TABLET should be used with caution in breastfeeding women. Safety and effectiveness of SITAZIT D 10/50 TABLET in children and adolescents (under 18 years of age) have not been established.

It is important to stay on the diet and exercise recommended by your doctor while taking SITAZIT D 10/50 TABLET as it can help your body use its blood sugar better. The most common side effects of taking SITAZIT D 10/50 TABLET are nausea, headache, flatulence and constipation. Consult your doctor if any of the side effects worsen or persist for a long period of time.

USES OF SITAZIT D 10/50 TABLET

  • Treats type II diabetes mellitus (which is inadequately controlled on metformin monotherapy)

HOW SITAZIT D 10/50 TABLET WORKS

SITAZIT D 10/50 TABLET effectively controls blood sugar levels where dapagliflozin inhibits SGLT2, increasing urinary glucose excretion and reducing blood levels of glucose and sitagliptin inhibits DPP-4, increases glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), resulting in increased insulin synthesis and decreased glucagon release.

DIRECTIONS FOR USE

Take SITAZIT D 10/50 TABLET as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. SITAZIT D 10/50 TABLET can be taken with or without food. Your doctor will decide the correct dose and duration of SITAZIT D 10/50 TABLET treatment depending on your age, body weight and disease condition.

SIDE EFFECTS OF SITAZIT D 10/50 TABLET

COMMON

  • nausea, vomiting
  • flatulence, constipation
  • swelling of hands or legs
  • headache, dizziness
  • stuffy or runny nose, sore throat
  • osteoarthritis
  • back, arm or leg pain
  • infection (thrush) of the penis or vagina (irritation, itching, unusual discharge or odor)
  • passing urine more often
  • rash

UNCOMMON

  • stomach pain, diarrhea
  • drowsiness
  • dry mouth
  • itching
  • waking up at night to urinate
  • dehydration (dry or sticky mouth, passing little or no urine or fast heartbeat)
  • thirst
  • weight decreased

RARE

  • angioedema (swollen face, tongue or throat, trouble swallowing and breathing, hives)

Stop taking SITAZIT D 10/50 TABLET and contact your physician immediately if you experience any of the following side effects:

  • inflamed pancreas (severe and persistent stomach pain that might reach through the back with or without nausea and vomiting)
  • serious allergic reaction (rash, hives, blisters on the skin or peeling skin and swelling of the lips, tongue, face and throat that may cause difficulty in breathing or swallowing)
  • necrotising fasciitis of the perineum or Fournier’s gangrene (serious soft tissue infection of the genitals or the area between the genitals and the anus causing pain, tenderness, redness or swelling)
  • diabetic ketoacidosis (increased levels of ketone bodies in urine or blood, nausea or vomiting, stomach ache, excessive thirst, fast and deep breathing, confusion, unusual sleepiness or tiredness, a sweet smell to breathe, a sweet or metallic taste in the mouth or a different odor in urine or sweat, rapid weight loss)
  • urinary tract infection (fever, chills, burning sensation when passing urine, pain in the back or side, blood in urine)
  • low blood sugar levels (shaking, sweating, feeling very anxious, fast heartbeat, feeling hungry, headache, change in vision, and a change in mood or feeling confused)

HOW TO MANAGE SIDE EFFECTS

Constipation

Eat plenty of fiber-rich foods such as fresh fruits, vegetables, cereals and drink plenty of water. Exercise more regularly. If symptom persists, consult your doctor.

Nausea And Vomiting

Take SITAZIT D 10/50 TABLET with or just after a meal or a snack. Stick to simple meals. Avoid eating oil rich or spicy food. If symptom persists, consult your doctor.

Dry Mouth

Sip water regularly and other sugar free liquids. Do not use mouthwashes that contain alcohol because they can make your mouth dry, use mouthwash that is used only for dry mouth. Limit your caffeine intake. Avoid smoking or using tobacco products. Consult your doctor if the symptom does not improve.  

Headache

Rest and relax. Keep yourself hydrated by drinking more fluids like water. Applying a pain-relieving balm on the forehead can be beneficial. Avoid consumption of alcohol, as it could aggravate your headache. If symptom persists, consult your doctor.

WARNING & PRECAUTIONS

PREGNANCY
Monitoring required

SITAZIT D 10/50 TABLET should be used in pregnant women only if considered clearly necessary. Consult your before taking it.

BREASTFEEDING
Use with Caution

SITAZIT D 10/50 TABLET should be used with caution in breastfeeding women. Consult your before taking it.

DRIVING AND USING MACHINES
Use with Caution

Do not drive or operate any machines if you feel dizzy or sleepy after taking SITAZIT D 10/50 TABLET.

ALCOHOL
Consult your doctor

Avoid consumption of alcohol while taking SITAZIT D 10/50 TABLET as it may increase the chances of diabetic ketoacidosis. Consult your doctor for advice.

KIDNEY
Use with Caution

SITAZIT D 10/50 TABLET should be used with caution in patients who had or have any kidney problems. Consult your doctor before taking SITAZIT D 10/50 TABLET.

LIVER
Use with Caution

SITAZIT D 10/50 TABLET should be used with caution in patients with severe liver impairment. Consult your doctor before taking SITAZIT D 10/50 TABLET.

ALLERGY
Contraindicated

Do not take SITAZIT D 10/50 TABLET if you are allergic to Dapagliflozin, Sitagliptin or any other ingredients of this medicine.

HEART DISEASE
Use with Caution

SITAZIT D 10/50 TABLET should be used with caution in patients who ever had heart failure. Consult your doctor before taking SITAZIT D 10/50 TABLET.

USE IN PEDIATRICS
Consult your doctor

Safety and effectiveness of SITAZIT D 10/50 TABLET in children and adolescents (under 18 years of age) have not been established. Consult your child’s doctor for advice.

USE IN GERIATRICS
Consult your doctor

No dose adjustment of SITAZIT D 10/50 TABLET is required for elderly patients, however, consult your doctor before taking it.

OTHERS

SITAZIT D 10/50 TABLET is not recommended for use if you have:

  • type I diabetes mellitus
  • diabetic ketoacidosis (enhanced levels of ketone bodies in the blood)

Before taking SITAZIT D 10/50 TABLET inform your doctor if you:

  • have inflammation of the pancreas
  • have gallstones
  • have alcohol dependence
  • have very high levels of triglycerides (a form of fat) in the blood
  • are fasting
  • are dehydrated

INTERACTIONS

A. Drug-Drug interactions:

Before taking SITAZIT D 10/50 TABLET, inform your doctor if you are taking any of the following medicines:

  • medicines used to treat fungal infections (Ex. ketoconazole, itraconazole)
  • ritonavir (used to treat HIV)
  • clarithromycin (used to treat bacterial infections)
  • ciclosporin (used to stop organ transplant rejection)
  • digoxin (used to treat heart problems)
  • medicines used to treat fluid retention (Ex. hydrochlorothiazide, furosemide)
  • other medicines used to treat diabetes (Ex. metformin, insulin, glimepiride)

Overdosage:

If you or anyone else accidentally take too much of SITAZIT D 10/50 TABLET, consult your doctor or visit a nearby hospital immediately.

SYNOPSIS

Drug :   Dapagliflozin, Sitagliptin
Pharmacological Category :   Sodium-Glucose Cotransporter 2 (SGLT2) inhibitor, Dipeptidyl Peptidase 4 (DPP-4) inhibitor
Therapeutic Indication :   Type II diabetes mellitus
Dosage Forms :   Tablet

MORE INFORMATION

  • Keep SITAZIT D 10/50 TABLET out of reach of children
  • Store SITAZIT D 10/50 TABLET below 30°C

FAQs ABOUT SITAZIT D 10/50 TABLET

Q: What is SITAZIT D 10/50 TABLET and why is it prescribed?

A: SITAZIT D 10/50 TABLET is a combination of Dapagliflozin and Sitagliptin which belongs to the group of medicines called Antidiabetic agents. It is used in adults to treat type II diabetes mellitus which is inadequately controlled on metformin monotherapy.

Q: Does SITAZIT D 10/50 TABLET cause weight loss?

A: Yes, SITAZIT D 10/50 TABLET may cause weight loss in some individuals. To avoid weight loss, follow a healthy diet and regular physical activity as advised by your physician. However, if the weight loss bothers you, consult your doctor.

Q: Can SITAZIT D 10/50 TABLET be taken along with insulin?

A: Taking SITAZIT D 10/50 TABLET along with insulin might increase the chances of hypoglycemia (decreased blood sugar levels). Consult your doctor before taking any other medicine with SITAZIT D 10/50 TABLET.

Q: How does SITAZIT D 10/50 TABLET work?

A: SITAZIT D 10/50 TABLET effectively controls blood sugar levels where dapagliflozin inhibits SGLT2, increasing urinary glucose excretion and reducing blood levels of glucose and sitagliptin inhibits DPP-4, increases glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), resulting in increased insulin synthesis and decreased glucagon release.

Q: Is SITAZIT D 10/50 TABLET safe to use in patients with kidney problems?

A: SITAZIT D 10/50 TABLET should be used with caution in patients who had or have any kidney problems. Your doctor may monitor your kidney function test before and during treatment with this medicine to prevent the risk of any unusual effects. Consult your doctor before taking SITAZIT D 10/50 TABLET.

REFERENCES

1. KD. Tripathi. Insulin, Oral Antidiabetic Drugs and Glucagon. Essentials of Medical Pharmacology. Eighth edition. 2019. Page – 297 & 301

2. Serge A. Jabbour; Elise Hardy; Jennifer Sugg; Shamik Parikh. Dapagliflozin Is Effective as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Journal of Diabetes care. American Diabetes Association. February 2014. [Accessed on 18th November 2022] https://diabetesjournals.org/care/article/37/3/740/29499/Dapagliflozin-Is-Effective-as-Add-on-Therapy-to

3. Annaswamy Raji, Zhi Jin Xu, Raymond L. H. Lam, Edward A.O’Neill, Keith D. Kaufman, Samuel S. Engel. Ef?cacy and Safety of Sitagliptin Compared with Dapagli?ozin in People ≥65 Years Old with Type 2 Diabetes and Mild Renal Insuf?ciency. SpringerLink. August 2020. [Accessed on 18th November 2022] https://link.springer.com/article/10.1007/s13300-020-00907-w

4. Torrent Pharmaceuticals Ltd. Sitaxa D/ Sitalix D/Glucreta S (Dapagliflozin + Sitagliptin). [Revised in July 2022] [Accessed on 18th November 2022] https://www.torrentian.com/pisheet/Upload/PI_Sheet/3096.pdf

5. Cipla Ltd. Exemed Pharmaceuticals. Darasach S (Dapagliflozin + Sitagliptin). Ciplamed. [Revised in September 2022] [Accessed on 18th November 2022] https://www.ciplamed.com/content/dapasach-s-tablets

USEFUL DIAGNOSTIC TESTS

  • Glucose - Fasting Blood
  • Glucose - Postprandial Blood
  • Glycosylated Hemoglobin

PRODUCT DETAILS

    Country Of Origin
    India
GET EXTRA DISCOUNT
Get upto 20%

Additional Discount on this product

Please get a call back from our expert

ALTERNATE BRANDS View All
SITACIP D 50/10 Tablet 10's
Prescription Diabetes Rx required
Rs.120.00
DAPASACH S 10/50 Tablet 10's
Prescription Diabetes Rx required
Rs.120.00
EMSITA D 50/10 Tablet 10's
Prescription Diabetes Rx required
Rs.199.00
DISCLAIMER

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

SITAZIT D 10/50 Tablet 10's

SITAZIT D 10/50 Tablet 10's Mkt: Glenmark Pharmaceuticals Ltd

₹ 138.58 MRP ₹ 169.00